Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Fragment-based Drug Discovery Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 NMR Spectroscopy Market Performance (Volume)
2.1.2 DSF Assay Market Performance (Volume)
2.1.3 Fluorescence Polarization (FP) Market Performance (Volume)
2.1.4 Isothermal Titration Calorimetry (ITC) Market Performance (Volume)
2.1.5 X-ray Crystallography Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 NMR Spectroscopy Market Performance (Value)
2.2.2 DSF Assay Market Performance (Value)
2.2.3 Fluorescence Polarization (FP) Market Performance (Value)
2.2.4 Isothermal Titration Calorimetry (ITC) Market Performance (Value)
2.2.5 X-ray Crystallography Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Biopharmaceutical Companies Market Performance (Volume)
3.1.2 CROs Market Performance (Volume)
3.1.3 Academic and Research Institutions Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Astex Pharmaceuticals
4.1.1 Astex Pharmaceuticals Profiles
4.1.2 Astex Pharmaceuticals Product Information
4.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Business Performance
4.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Business Development and Market Status
4.2 Alveus Pharmaceuticals Pvt. Ltd
4.2.1 Alveus Pharmaceuticals Pvt. Ltd Profiles
4.2.2 Alveus Pharmaceuticals Pvt. Ltd Product Information
4.2.3 Alveus Pharmaceuticals Pvt. Ltd Fragment-based Drug Discovery Business Performance
4.2.4 Alveus Pharmaceuticals Pvt. Ltd Fragment-based Drug Discovery Business Development and Market Status
4.3 Beactica AB
4.3.1 Beactica AB Profiles
4.3.2 Beactica AB Product Information
4.3.3 Beactica AB Fragment-based Drug Discovery Business Performance
4.3.4 Beactica AB Fragment-based Drug Discovery Business Development and Market Status
4.4 Charles River Laboratories International, Inc
4.4.1 Charles River Laboratories International, Inc Profiles
4.4.2 Charles River Laboratories International, Inc Product Information
4.4.3 Charles River Laboratories International, Inc Fragment-based Drug Discovery Business Performance
4.4.4 Charles River Laboratories International, Inc Fragment-based Drug Discovery Business Development and Market Status
4.5 Crown Bioscience, Inc
4.5.1 Crown Bioscience, Inc Profiles
4.5.2 Crown Bioscience, Inc Product Information
4.5.3 Crown Bioscience, Inc Fragment-based Drug Discovery Business Performance
4.5.4 Crown Bioscience, Inc Fragment-based Drug Discovery Business Development and Market Status
4.6 Emerald BioStructures, Inc
4.6.1 Emerald BioStructures, Inc Profiles
4.6.2 Emerald BioStructures, Inc Product Information
4.6.3 Emerald BioStructures, Inc Fragment-based Drug Discovery Business Performance
4.6.4 Emerald BioStructures, Inc Fragment-based Drug Discovery Business Development and Market Status
4.7 Evotec AG
4.7.1 Evotec AG Profiles
4.7.2 Evotec AG Product Information
4.7.3 Evotec AG Fragment-based Drug Discovery Business Performance
4.7.4 Evotec AG Fragment-based Drug Discovery Business Development and Market Status
4.8 Kinetic Discovery Limited
4.8.1 Kinetic Discovery Limited Profiles
4.8.2 Kinetic Discovery Limited Product Information
4.8.3 Kinetic Discovery Limited Fragment-based Drug Discovery Business Performance
4.8.4 Kinetic Discovery Limited Fragment-based Drug Discovery Business Development and Market Status
4.9 Proteros Fragments GmbH
4.9.1 Proteros Fragments GmbH Profiles
4.9.2 Proteros Fragments GmbH Product Information
4.9.3 Proteros Fragments GmbH Fragment-based Drug Discovery Business Performance
4.9.4 Proteros Fragments GmbH Fragment-based Drug Discovery Business Development and Market Status
4.10 Sprint Bioscience
4.10.1 Sprint Bioscience Profiles
4.10.2 Sprint Bioscience Product Information
4.10.3 Sprint Bioscience Fragment-based Drug Discovery Business Performance
4.10.4 Sprint Bioscience Fragment-based Drug Discovery Business Development and Market Status
4.11 Structure Based Design, Inc
4.12 Sygnature Discovery
5 Market Performance for Manufacturers
5.1 Europe Fragment-based Drug Discovery Sales (K Units) and Market Share by Manufacturers 2014-2019
5.2 Europe Fragment-based Drug Discovery Revenue (M USD) and Market Share by Manufacturers 2014-2019
5.3 Europe Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
5.4 Europe Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.1.2 Germany Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.1.3 Germany Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.1.4 Germany Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.2.2 UK Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.2.3 UK Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.2.4 UK Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.3.2 France Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.3.3 France Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.3.4 France Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.4.2 Russia Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.4.3 Russia Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.4.4 Russia Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.5.2 Benelux Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.5.3 Benelux Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.5.4 Benelux Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.6.2 Italy Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.6.3 Italy Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.6.4 Italy Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.7.2 Spain Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.7.3 Spain Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.7.4 Spain Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Fragment-based Drug Discovery Sales (K Units) and Share of Manufacturers 2014-2019
6.8.2 Fragment-based Drug Discovery Revenue (M USD) and Share of Manufacturers 2014-2019
6.8.3 Fragment-based Drug Discovery Price (USD/Unit) of Manufacturers 2014-2019
6.8.4 Fragment-based Drug Discovery Gross Margin of Manufacturers 2014-2019
6.8.5 Market Concentration
7 Europe Fragment-based Drug Discovery Market Performance (Sales Point)
7.1 Europe Fragment-based Drug Discovery Sales (K Units) and Market Share by Regions 2014-2019
7.2 Europe Fragment-based Drug Discovery Revenue (M USD) and Market Share by Regions 2014-2019
7.3 Europe Fragment-based Drug Discovery Price (USD/Unit) by Regions 2014-2019
7.4 Europe Fragment-based Drug Discovery Gross Margin by Regions 2014-2019
8 Development Trend for Regions (Sales Point)
8.1 Europe Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.2 Germany Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.3 UK Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.4 France Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.5 Russia Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.6 Benelux Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.7 Italy Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
8.8 Spain Fragment-based Drug Discovery Sales and Growth, Sales Value and Growth Rate2014-2019
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Biopharmaceutical Companies Industry
11.2 CROs Industry
11.3 Academic and Research Institutions Industry
12 Market Forecast 2020-2025
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
12.1.1 Europe Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
12.1.2 Europe Fragment-based Drug Discovery Sales (K Units) and Growth Rate 2020-2025
12.1.3 Germany Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.4 UK Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.5 France Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.6 Russia Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.7 Benelux Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.8 Italy Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.9 Spain Fragment-based Drug Discovery Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2025
12.2.1 Overall Market Performance
12.2.2 NMR Spectroscopy Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.3 DSF Assay Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.4 Fluorescence Polarization (FP) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.5 Isothermal Titration Calorimetry (ITC) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.6 X-ray Crystallography Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.3 Sales Forecast by Application 2020-2025
12.3.1 Overall Market Performance
12.3.2 Biopharmaceutical Companies Sales and and Growth Rate 2020-2025
12.3.3 CROs Sales and and Growth Rate 2020-2025
12.3.4 Academic and Research Institutions Sales and and Growth Rate 2020-2025
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Fragment-based Drug Discovery Price (USD/Unit) Trend 2020-2025
12.4.2 Europe Fragment-based Drug Discovery Gross Profit Trend 2020-2025
13 Conclusion